Peptinnovate Ltd logo — company profile

Peptinnovate Ltd

Founded 2011 2-10 employees Series Unknown Total: $4.01M Health and Wellness, Pharmaceutical

General Information

Company Name Peptinnovate Ltd
Founded Year 2011
Employees 2-10
Industries Health and Wellness, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Peptinnovate Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Peptinnovate Ltd

Peptinnovate Ltd, founded in 2011, is a pharmaceutical company that focuses on researching and developing innovative new therapies to address immuno-inflammatory diseases such as asthma, atopic dermatitis, and inflammatory bowel disease. These diseases are characterized by chronic inflammation, which, if left uncontrolled, can lead to organ damage and loss of function, resulting in increased morbidity and mortality for a large portion of the population. The company aims to significantly advance the control and management of moderate to severe chronic inflammatory diseases, with the potential for disease modification and remission through their drug development efforts. In July 2018, Peptinnovate Ltd received a £217.94K investment in a Venture Round, with 24Haymarket as the investor. The company is now moving into the exciting phase of clinical development to prove the safety and efficacy of their products. With a focus on addressing critical unmet medical needs, Peptinnovate Ltd is poised to make a substantial impact in the pharmaceutical industry by providing novel treatment options for immuno-inflammatory diseases.

Taxonomy: Immunology, Inflammatory diseases, Drug development, Therapeutics, Clinical research, Safety, Efficacy, Chronic inflammation, Therapy development, Disease modification, Remission, Clinical trials, Pharmaceuticals, Healthcare innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
01 Jul 2018
Venture Round •••••• 1
Investor
01 Mar 2018
Series A •••••• 2 •••• •••• 17 Jun 2017

Peptinnovate Ltd Alternatives & Competitors

Peptinnovate Ltd vs
Avalo Therapeutics
Avalo Therapeutics United States

Innovation driven by compassion.

Post Ipo Equity
48 employees
Biotechnology, Health and Wellness
Peptinnovate Ltd vs

KUSTE is a Clinical Stage Biopharma Company founded by seasoned entrepreneurs in Life Science

1 employees
Biopharma, Biotechnology
Peptinnovate Ltd vs

Advancing therapeutic innovation in human cell signaling for inflammation, fibrosis, and CNS disease...

Series C
Biotechnology, Health Care

FAQ About Peptinnovate Ltd

Immuno-inflammatory diseases, including asthma, atopic dermatitis and inflammatory bowel disease, result from a poorly controlled or overactive immune response. Affecting a large proportion of the population these diseases are characterised by an increase in chronic inflammation which, if left unche...
Peptinnovate Ltd was founded in 2011.
Peptinnovate Ltd operates in the following industries: Health and Wellness, Pharmaceutical.
Peptinnovate Ltd has approximately 2-10 employees.
Peptinnovate Ltd has completed 3 funding rounds, raising a total of $4.01M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Peptinnovate Ltd include Avalo Therapeutics, KUSTE BIOPHARMA, Complexa, 13therapeutics, Kynos Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Peptinnovate Ltd and Avalo Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Peptinnovate Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy